INCY:NASDAQ
Incyte Corp
112,73 $
arrow_downward
-1,23%(-1,40) 1D
112,67 $
arrow_downward
-0,05% (-0,061)bedtimeAfter hours
Closed: 6 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
114,13 $
High
114,97 $
Low
111,67 $
Mkt. cap
23,08 մլրդ
Avg. vol.
1,50 մլն
Volume
2,46 մլն
P/E ratio
14,36
52-wk high
132,60 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,74
Shares outstanding
202,70 մլն
No. of employees
3 հզր
Open
114,13 $
High
114,97 $
Low
111,67 $
Mkt. cap
23,08 մլրդ
Avg. vol.
1,50 մլն
Volume
2,46 մլն
P/E ratio
14,36
52-wk high
132,60 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,74
Shares outstanding
202,70 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
News Corp
·
2 ժամ առաջ
Incyte Corp. stock underperforms Tuesday when compared to competitors
MarketWatch
·
2 ժամ առաջ
Incyte Corp. stock underperforms Tuesday when compared to competitors
AD HOC NEWS
·
11 ժամ առաջ
Incyte stock gets a USD 157 Stifel price target after pipeline update
Kalkine Media
·
13 ժամ առաջ
What Will Decide the Next Move in Incyte (NASDAQ:INCY)?
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 հզր
Founded2002
HeadquartersՈւիլմինգտոն, Դելավեր, Միացյալ Նահանգներ
Sector-
Websiteincyte.com